JP2024510778A5 - - Google Patents

Info

Publication number
JP2024510778A5
JP2024510778A5 JP2023558324A JP2023558324A JP2024510778A5 JP 2024510778 A5 JP2024510778 A5 JP 2024510778A5 JP 2023558324 A JP2023558324 A JP 2023558324A JP 2023558324 A JP2023558324 A JP 2023558324A JP 2024510778 A5 JP2024510778 A5 JP 2024510778A5
Authority
JP
Japan
Application number
JP2023558324A
Other languages
Japanese (ja)
Other versions
JP2024510778A (ja
JPWO2022201097A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/052720 external-priority patent/WO2022201097A1/en
Publication of JP2024510778A publication Critical patent/JP2024510778A/ja
Publication of JPWO2022201097A5 publication Critical patent/JPWO2022201097A5/ja
Publication of JP2024510778A5 publication Critical patent/JP2024510778A5/ja
Pending legal-status Critical Current

Links

JP2023558324A 2021-03-26 2022-03-24 1,3-置換シクロブチル誘導体及びその使用 Pending JP2024510778A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163166289P 2021-03-26 2021-03-26
US63/166,289 2021-03-26
PCT/IB2022/052720 WO2022201097A1 (en) 2021-03-26 2022-03-24 1,3-substituted cyclobutyl derivatives and uses thereof

Publications (3)

Publication Number Publication Date
JP2024510778A JP2024510778A (ja) 2024-03-11
JPWO2022201097A5 JPWO2022201097A5 (https=) 2025-04-01
JP2024510778A5 true JP2024510778A5 (https=) 2025-04-01

Family

ID=80999265

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023558324A Pending JP2024510778A (ja) 2021-03-26 2022-03-24 1,3-置換シクロブチル誘導体及びその使用

Country Status (14)

Country Link
US (2) US11845730B2 (https=)
EP (1) EP4313951A1 (https=)
JP (1) JP2024510778A (https=)
KR (1) KR20230162660A (https=)
CN (1) CN117062804A (https=)
AR (1) AR125196A1 (https=)
AU (1) AU2022244467A1 (https=)
CA (1) CA3214066A1 (https=)
IL (1) IL307189A (https=)
MX (1) MX2023011377A (https=)
PY (1) PY2221203A (https=)
TW (1) TW202304864A (https=)
UY (1) UY39681A (https=)
WO (1) WO2022201097A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR125196A1 (es) * 2021-03-26 2023-06-21 Novartis Ag Derivados de ciclobutilo 1,3-sustituidos y sus usos
WO2024062389A1 (en) * 2022-09-21 2024-03-28 Bausch + Lomb Ireland Limited Crystalline polymorph forms of a trpv1 antagonist and formulations thereof
US20240148709A1 (en) * 2022-11-08 2024-05-09 Aisa Pharma, Inc. Methods of treating eye pain and eye disorders

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078163A2 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
US6933311B2 (en) * 2003-02-11 2005-08-23 Abbott Laboratories Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
US7514562B2 (en) * 2003-03-07 2009-04-07 Glaxo Group Limited Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain
GB0412769D0 (en) 2004-06-08 2004-07-07 Novartis Ag Organic compounds
RU2451014C2 (ru) 2005-07-22 2012-05-20 Мотида Фармасьютикал Ко., Лтд. Новое производное гетероциклиден ацетамида
EP2050734A1 (en) 2006-07-13 2009-04-22 Kyowa Hakko Kirin Co., Ltd. Pentadienamide derivative
NZ577980A (en) 2006-12-27 2012-01-12 Sanofi Aventis Cycloalkylamine substituted isoquinolone derivatives
WO2012072512A1 (en) * 2010-11-29 2012-06-07 Glaxo Group Limited N-cyclobutyl-imidazopyridine or -pyrazolopyridine carboxamides as trpv1 antagonists
DE102010052781A1 (de) 2010-11-30 2012-05-31 Trw Automotive Gmbh Befestigungsvorrichtung und Befestigungsbaugruppe zur Befestigung eines Gasgenerators und Fahrzeuginsassenrückhaltesystem
TW201302681A (zh) * 2011-03-25 2013-01-16 Abbott Lab Trpv1拮抗劑
JP2014510768A (ja) * 2011-04-11 2014-05-01 グラクソ グループ リミテッド Trpv1アンタゴニストとしてのn−シクロブチルイミダゾピリジンメチルアミン
US9747862B2 (en) 2015-11-02 2017-08-29 Castar, Inc. Method of immersive rendering for wide field of view
US10269906B2 (en) * 2016-11-30 2019-04-23 Taiwan Semiconductor Manufacturing Co., Ltd. Semiconductor device having two spacers
WO2018151678A1 (en) * 2017-02-15 2018-08-23 Agency For Science, Technology And Research Compounds for treatment of cancer and epigenetics
US11542248B2 (en) 2017-06-08 2023-01-03 Kura Oncology, Inc. Methods and compositions for inhibiting the interaction of menin with MLL proteins
AU2019392904B9 (en) 2018-12-07 2022-12-22 University Of Maryland, Baltimore Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors
AR125196A1 (es) * 2021-03-26 2023-06-21 Novartis Ag Derivados de ciclobutilo 1,3-sustituidos y sus usos

Similar Documents

Publication Publication Date Title
CL2025003455A1 (es) Forma cristalina de 4-(((etil(metil)amino)metilen)amino)-2,5-dimetilbenzoato de 4-(difluorometoxi)bencilo o una de sus sales y uso como fungicida.
JP2024510778A5 (https=)
BR102022025291A2 (https=)
CL2025004061A1 (es) Filtro, componente de filtro y sistema de conectores de filtro con lengüetas de enclavamiento y elementos de retención
CL2025004008A1 (es) Tapa con composición de barrera
CA3238131A1 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13175U (https=)
CN307045992S (https=)
BY13176U (https=)
BY13149U (https=)